93 related articles for article (PubMed ID: 8491314)
1. Early changes in the 1H-NMR plasma spectrum in patients following breast surgery.
Engan T; Krane J; Søreide JA; Bjerve KS; Kvinnsland S
Eur J Surg Oncol; 1993 Apr; 19(2):115-22. PubMed ID: 8491314
[TBL] [Abstract][Full Text] [Related]
2. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
Fossel ET; Carr JM; McDonagh J
N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
[TBL] [Abstract][Full Text] [Related]
3. Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.
Mims MP; Morrisett JD; Mattioli CA; Gotto AM
N Engl J Med; 1989 Jun; 320(22):1452-7. PubMed ID: 2716796
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer.
Engan T; Bjerve KS; Høe AL; Krane J
Scand J Clin Lab Invest; 1992 Sep; 52(5):393-408. PubMed ID: 1514018
[TBL] [Abstract][Full Text] [Related]
5. Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy.
Engan T; Krane J; Johannessen DC; Lønning PE; Kvinnsland S
Breast Cancer Res Treat; 1995; 36(3):287-97. PubMed ID: 8573711
[TBL] [Abstract][Full Text] [Related]
6. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging.
Engan T; Krane J; Kvinnsland S
NMR Biomed; 1991 Jun; 4(3):142-9. PubMed ID: 1911102
[TBL] [Abstract][Full Text] [Related]
7. Significance of alterations in plasma lipid profile levels in breast cancer.
Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel
Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
[TBL] [Abstract][Full Text] [Related]
8. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
9. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
10. [NMR research on blood plasma for tumor detection--a method for mass screening?].
Fritzsche H; Sprinz H; Jahn H; Jorke D
Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
[TBL] [Abstract][Full Text] [Related]
11. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.
Bathen TF; Engan T; Krane J; Axelson D
Anticancer Res; 2000; 20(4):2393-408. PubMed ID: 10953302
[TBL] [Abstract][Full Text] [Related]
12. [Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins].
Nabholtz JM; Tremeaux JC; Rossignol A; Farnier M; Gambert P; Briet S; Guerrin J
J Urol (Paris); 1989; 95(4):209-12. PubMed ID: 2477463
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
14. The NMR blood test for cancer: current status.
Fossel ET
Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
[TBL] [Abstract][Full Text] [Related]
15. Effect of surgical castration on risk factors for arteriosclerosis of patients with prostate cancer.
Xu T; Wang X; Hou S; Zhu J; Zhang X; Huang X
Chin Med J (Engl); 2002 Sep; 115(9):1336-40. PubMed ID: 12411107
[TBL] [Abstract][Full Text] [Related]
16. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
[TBL] [Abstract][Full Text] [Related]
18. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
19. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
[TBL] [Abstract][Full Text] [Related]
20. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
